Marcel Zwaal

Marcel is a corporate finance and business professional with over 15 years of experience in the medical innovation and biotechnology field. He has supported and managed many innovative companies through their growth stages, from start-up to IPO and stock market listing. Marcel has worked in Corporate Development at Galapagos and Kiadis, served as CEO at several early-stage biotech companies, and held senior management positions at Crucell prior to its acquisition by Johnson & Johnson in 2011. He holds an Executive Master of Finance and Control and a Finance BA MSc degree.